These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7995054)

  • 1. The identification of drug resistance in ovarian cancer and breast cancer: application of the MTT assay.
    Sargent J; Elgie A; Taylor CG; Wilson J; Alton P; Hill JG
    Contrib Gynecol Obstet; 1994; 19():64-75. PubMed ID: 7995054
    [No Abstract]   [Full Text] [Related]  

  • 2. [A trial of isolation in chemotherapy for gynecological malignant tumor by MTT assay].
    Sato Y; Igarashi S; Higuchi J; Soga K; Tanaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Dec; 45(12):1421-4. PubMed ID: 8270830
    [No Abstract]   [Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy in inoperable, locally advanced, and inflammatory breast carcinoma: a pilot study of MTT assay in vitro and outcome analysis of 10 patients.
    Xu JM; Song ST; Tang ZM; Jiang ZF; Liu XQ; Zhang J; Liu XW; Paradiso A
    Am J Clin Oncol; 2001 Jun; 24(3):259-63. PubMed ID: 11404497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemosensitivity testing predicts survival in ovarian cancer.
    Taylor CG; Sargent JM; Elgie AW; Williamson CJ; Lewandowicz GM; Chappatte O; Hill JG
    Eur J Gynaecol Oncol; 2001; 22(4):278-82. PubMed ID: 11695809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MTT assay for detecting 5-fluorouracil chemosensitivity of human breast carcinoma cell line].
    Han FX; Lin H; Ru L
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):97-9. PubMed ID: 19218124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenic assay.
    Shimoyama Y; Kubota T; Watanabe M; Ishibiki K; Abe O
    J Surg Oncol; 1989 May; 41(1):12-8. PubMed ID: 2716329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictive chemotherapy of breast cancer directed by MTT assay in vitro].
    Xu J; Song S; Tang Z
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):153-6. PubMed ID: 10743085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Key points and problems concerning chemosensitivity tests, with special reference to MTT assay].
    Nishida M; Kohno K; Nishide K
    Hum Cell; 1992 Mar; 5(1):87-98. PubMed ID: 1419954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium succinate enhances the colorimetric reaction of the in vitro chemosensitivity test: MTT assay.
    Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sugimachi K
    Oncology; 1988; 45(6):434-6. PubMed ID: 3186153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tetrazolium-based colorimetric assay (MTT) and its application in chemosensitivity testing of antitumor Chinese medicine].
    Wu JZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 Nov; 27(6):373-5. PubMed ID: 1307965
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical relevance of chemosensitivity testing in ovarian cancer.
    Taylor CG; Sargent JM; Elgie AW; Reid FD; Alton PA; Hill JG
    Cancer Detect Prev; 1998; 22(4):305-12. PubMed ID: 9674873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sensitivity test for anti-tumor agents-3. MTT assay and its clinical effect].
    Wada Y; Tomiyoshi Y; Fujimaru J; Ogura M; Hirabayashi K; Yoshida S; Takeda Y
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2349-54. PubMed ID: 1463341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy.
    Wilson JK; Sargent JM; Elgie AW; Hill JG; Taylor CG
    Br J Cancer; 1990 Aug; 62(2):189-94. PubMed ID: 2386733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs.
    Chen CF; Hwang JM; Wu CH; Chen CS; Chen KY
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jul; 46(1):7-16. PubMed ID: 2176928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A prospective study of adenosine triphosphate-tumor chemosensitivity assay directed chemotherapy in patients with recurrent ovarian cancer].
    Gao YT; Wu LY; Zhang W; Zhao D; Li N; Tian HM; Wang XB; Li M; Sun YC; Li N; Li XG
    Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):358-63. PubMed ID: 24016479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro.
    Xu JM; Song ST; Tang ZM; Jiang ZF; Liu XQ; Zhou L; Zhang J; Liu XW
    Breast Cancer Res Treat; 1999 Jan; 53(1):77-85. PubMed ID: 10206075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents.
    Fricker SP; Buckley RG
    Anticancer Res; 1996; 16(6B):3755-60. PubMed ID: 9042253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of the tetrazolium derivative reduction (MTT) and digital cell image analysis to monitor in vitro the cytotoxicity of anti-neoplastic drugs.
    Etievant C; Kruczynski A; Pauwels O; Kiss R
    Anticancer Res; 1991; 11(1):305-11. PubMed ID: 2018364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.
    Carmichael J; DeGraff WG; Gazdar AF; Minna JD; Mitchell JB
    Cancer Res; 1987 Feb; 47(4):936-42. PubMed ID: 3802100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference by anti-cancer chemotherapeutic agents in the MTT-tumor chemosensitivity assay.
    Ulukaya E; Colakogullari M; Wood EJ
    Chemotherapy; 2004 Apr; 50(1):43-50. PubMed ID: 15084806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.